Venus Remedies ties up with Teva

September 01, 2014 11:26 pm | Updated 11:26 pm IST - CHENNAI:

Venus Remedies has entered into a collaborative agreement with Teva, the largest manufacturer of generic drugs in the world, for anti-cancer drug in the Canadian market. The high-potential drug is under patent protection till 2016. Under this collaboration, Venus will be initially manufacturing the drug at the Venus Medicine Research Centre, its research unit, for assisting Teva in registrations. Thereafter, it will also use its manufacturing capabilities to support Teva in enhancing the business from this drug in the Canadian market.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.